Rapport Therapeutics, Inc. (RAPP)
33.74
-1.66
(-4.69%)
USD |
NASDAQ |
Apr 28, 16:00
33.93
+0.19
(+0.56%)
Pre-Market: 20:00
Rapport Therapeutics EPS Diluted (Quarterly) : -0.7187 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint, Inc. | -0.8143 |
| Praxis Precision Medicines, Inc. | -3.500 |
| Bridgebio Oncology Therapeutics, Inc. | -0.485 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.76M |
| Total Expenses (Quarterly) | 33.76M |
| Enterprise Value | 1.133B |
| Earnings Yield | -8.49% |
| Normalized Earnings Yield | -8.491 |